Thomas Andrew Makin, MD
Allergy Physician · Wexford, PA
Thomas Andrew Makin, MD is an allergy physician with a practice address in Wexford, Pennsylvania, and NPI 1215426499, issued on May 3, 2018. Check the license (Pennsylvania MD487977, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Thomas Andrew Makin
- Credential
- MD
- Primary taxonomy
- Allergy Physician 207KA0200X
- License numbers
- MD487977 PA
0101276952 VA
Self-reported in NPPES; status is on the state search - Practice location
- 6500 Brooktree RD Ste 101, Wexford, PA 15090
- Phone
- (412) 359-6640
- Enumerated
- May 3, 2018
- Record last updated
- Apr 21, 2025
- Fax
- (412) 359-4148
- Medicaid ID
- 1215426499 VA
- Medicare enrollment
- Enrolled (PECOS I20250421002094); accepts Medicare assignment
- Entity
- Type 1 · individual
8 nearest allergy physician records → All 36 in Pennsylvania → Look up another NPI →
Also registered at 6500 Brooktree RD Ste 101
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Ashley Thrower, CRNPFamily Nurse Practitioner1790330801
Verify Thomas Andrew Makin in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MD487977Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
39% fewer Medicare Part D claims than the average allergy physician in 2024
458 Medicare Part D claims for 128 beneficiaries, against an average of 750 among the 645 providers of this specialty who prescribed in Part D. Brand-name drugs were 39% of claims.
Most prescribed
- Ipratropium Bromide45 claims
- Albuterol Sulfate Hfa37 claims
- Hydrocortisone30 claims
- Montelukast Sodium29 claims
- Trelegy Ellipta28 claims
- Fluticasone Propionate26 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $1,820.94
83 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 502 providers of this specialty with any payment received $9,080.33 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Allegheny ClinicPittsburgh, PA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Thomas Andrew Makin among 36 allergy physician records in Pennsylvania
Thomas Andrew Makin, MD is one of 36 allergy physician records with a practice address in Pennsylvania. 72% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2018, is newer than 89% of them.
- NPI issued2018 · 89% of these records are older, 8% newer
- In a Medicare fileYes · 72% of these records are
- In the CMS Doctors and Clinicians fileYes · 42% of these records are
- Graduated2018 · median 1991 among the 15 with a school on file
- Record last updated2025 · 56% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207KA0200X and a Pennsylvania practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Allergy Physician providers in Pennsylvania
There are 36 allergy physician records in Pennsylvania.
All 36 in Pennsylvania → Every provider in Wexford → Allergy Physician nationwide →
The 8 allergy physician records with the nearest ZIP codes
- Barry Asman, M.D.Monroeville, PA 151461407801897
- Jerry Lynn, MDMonroeville, PA 151461245235704
- Frank Aloi, M.D.Beaver, PA 150091760527147
- Allyson Larkin, MDPittsburgh, PA 152241831237429
- Richard Green, M.D.Pittsburgh, PA 152381164427480
- Andrew Vayonis, M.D.Pittsburgh, PA 152381194720425
- James Deangelo, D.O.Pittsburgh, PA 152411922056530
- David Miller, M.D.Pittsburgh, PA 152411538117486
Common questions
What is Thomas Andrew Makin, MD's NPI number?
Thomas Andrew Makin, MD's National Provider Identifier (NPI) is 1215426499, issued on May 3, 2018. An NPI identifies a provider in billing; it is not a license.
Where is Thomas Andrew Makin, MD located?
The NPPES record lists a practice address at 6500 Brooktree RD Ste 101, Wexford, PA, 15090. Phone: (412) 359-6640. Providers update this record themselves, so call before visiting.
How can I verify Thomas Andrew Makin, MD's license?
NPPES lists Pennsylvania license number MD487977, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Thomas Andrew Makin, MD prescribe under Medicare Part D?
In 2024, Thomas Andrew Makin, MD had 458 Medicare Part D claims for 128 beneficiaries; the average among allergy physician prescribers was 750. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.